XML 31 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 634,460 $ (8,393,503)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Amortization expense of intangible assets and other assets 486,555 912,703
Depreciation and amortization of property and equipment 115,901 210,571
Provision for losses on accounts receivable    (75,875)
Amortization of discounts on notes payable 2,654,143 6,967,644
Interest expense in relation to issuance of convertible debt 1,289,074 268,486
Common stock issued as compensation    1,557,825
Common stock issued as payment of expenses    76,250
Stock option compensation expense    669,444
Gain on sale of investment (974,515)   
Gain on change in fair value of obligations to issue shares (9,127) (559,578)
Gain on settlement of debt    (225,000)
Gain on debt extinguishment (1,204,711)   
Loss on debt modification 3,000,205 936,776
Gain on settlement of accounts payable    (302,057)
Goodwill impairment    962,427
Impairment of intangible assets (1,774,921)   
Loss on abandonment of asset 123,101   
Loss on write-down of construction costs    113,543
Gain on change in fair value of derivative liability (9,507,874) (6,952,284)
(Increase) decrease in:    
Accounts receivable (90,646) 58,171
Inventories 111,642 (100,309)
Prepaid expenses and other current assets (44,455) (73,335)
Deposits and other non-current assets 525,542 (15,140)
Increase (decrease) in:    
Accounts payable 271,272 (1,023,474)
Accrued expenses 47,858 (231,269)
Deferred revenue    50,000
Net cash used in operating activities (796,654) (5,167,984)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (2,183) (1,060,988)
Patent costs (6,594) (27,828)
Purchase of other assets (495,000)  
Net cash used in investing activities (503,777) (1,088,816)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment of debt obligations    (125,000)
Deferred financing costs for short-term notes (85,000) (255,000)
Net proceeds from short-term notes 1,945,400 4,500,000
Net cash provided by financing activities 1,860,400 4,120,000
Net effect of exchange rate changes on cash (49,437) 86,488
NET INCREASE (DECREASE) IN CASH 510,532 (2,050,312)
Cash, beginning of year 254,783 3,039,941
Cash, end of period 765,315 989,629
Cash paid during the period for:    
Interest 34,223 23,267
Non-cash financing activities:    
Common stock issued to settle convertible notes obligations 3,922,316 6,395,624
Fair value of derivatives issued in conjunction with debt and equity financing 3,401,534 4,667,269
Discount on convertible note issued in connection with financings 2,112,461  
Exchange of investment to reduce convertible notes obligations 881,760   
Equipment acquired through assumption of accounts payable    696,329
Common stock issued as settlement of discontinued operations obligations    1,344,000
Common stock issued in connection with conversion of preferred stock    $ 4,219,000